A femtosecond laser corneal refractive surgery system and related consumables produced by an important upstream partner represented by GAUSH MEDITECH (02407) have obtained the Medical Device Registration Certificate from the National Medical Products Administration.

GAUSH MEDITECH (02407) announced that its wholly-owned subsidiary, Shanghai Gaoshi Mingwang Medical Equipment Co., Ltd. acted as the agent for an important upstream partner, Germany SCHWIND company, to launch a femtosecond laser corneal refractive surgery system (applicable scope: corneal flap production in femtosecond laser-assisted transepithelial corneal inlay surgery (Femto-LASIK surgery)) and its matching disposable eye fixation patient interface, which has obtained the medical device registration certificate approved by the National Medical Products Administration of the People's Republic of China. The main highlights of this system include: (i) the use of CenTrax intelligent center positioning and eyeball tracking technology, providing higher safety and predictability; (ii) the use of ultra-high laser frequency, with a laser scanning frequency of up to 4MHz, making the surgery more efficient and the patients more comfortable; (iii) an optimized curved integrated negative pressure ring, which conforms to the corneal curvature without causing deformation of the eyeball and cornea, providing higher patient comfort; and (iv) personalized ultra-thin corneal flaps, providing more space for personalized surgery, with a maximum flap diameter of 9.6 millimeters, providing an adequate treatment zone, especially suitable for hyperopia and mixed astigmatism treatment. The announcement stated that the approval of this surgical system and its matching consumables further enriches the group's product portfolio, especially in high-end surgical treatment products. The group will continue to bring more and better products and solutions to customers and patients.